Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37119
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHertzog P.J.en
dc.contributor.authorEid S.G.en
dc.contributor.authorMak J.en
dc.contributor.authorScoble J.en
dc.contributor.authorLovrecz G.en
dc.contributor.authorDeWeerd N.A.en
dc.contributor.authorStifter S.A.en
dc.contributor.authorMatthews A.Y.en
dc.contributor.authorMangan N.E.en
dc.contributor.authorFung K.Y.en
dc.contributor.authorDrew A.en
dc.contributor.authorTate M.D.en
dc.contributor.authorSoares Da Costa T.P.en
dc.contributor.authorHampsey D.en
dc.contributor.authorMayall J.en
dc.contributor.authorHansbro P.M.en
dc.contributor.authorMinambres A.G.en
dc.date.accessioned2021-05-14T12:37:02Zen
dc.date.available2021-05-14T12:37:02Zen
dc.date.copyright2018en
dc.date.created20180314en
dc.date.issued2018-03-14en
dc.identifier.citationJournal of Biological Chemistry. 293 (9) (pp 3168-3179), 2018. Date of Publication: 2018.en
dc.identifier.issn0021-9258en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/37119en
dc.description.abstractThe type I interferons (IFNs) are a family of cytokines with diverse biological activities, including antiviral, antiproliferative, and immunoregulatory functions. The discovery of the hormonally regulated, constitutively expressed IFN has suggested a function for IFNs in reproductive tract homeostasis and protection from infections, but its intrinsic activities are untested. We report here the expression, purification, and functional characterization of murine IFN (mIFN). Recombinant mIFN (rmIFN) exhibited an alpha-helical fold characteristic of type I IFNs and bound to IFNalpha/beta receptor 1 (IFNAR1) and IFNAR2, but, unusually, it had a preference for IFNAR1. Nevertheless, rmIFN induced typical type I IFN signaling activity, including STAT1 phosphorylation and activation of canonical type I IFN signaling reporters, demonstrating that it uses the JAK-STAT signaling pathway. We also found that rmIFN induces the activation of T, B, and NK cells and exhibits antiviral, antiproliferative, and antibacterial activities typical of type I IFNs, albeit with 100-1000-fold reduced potency compared with rmIFNalpha1 and rmIFNbeta. Surprisingly, although the type I IFNs generally do not display cross-species activities, rmIFN exhibited high antiviral activity on human cells, suppressing HIV replication and inducing the expression of known HIV restriction factors in human lymphocytes. Our findings define the intrinsic properties of murine IFN, indicating that it distinctly interacts with IFNAR and elicits pathogen-suppressing activity with a potency enabling host defense but with limited toxicity, appropriate for a protein expressed constitutively in a sensitive mucosal site, such as the reproductive tract.Copyright © 2018 by The American Society for Biochemistry and Molecular Biology, Inc.en
dc.languageEnglishen
dc.languageenen
dc.publisherAmerican Society for Biochemistry and Molecular Biology Inc. (9650 Rockville Pike, Bethesda MD 20814, United States)en
dc.relation.ispartofJournal of Biological Chemistryen
dc.titleDefining the distinct, intrinsic properties of the novel type i interferon, IFN.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1074/jbc.M117.800755en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid29187603 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29187603]en
dc.identifier.source620929227en
dc.identifier.institution(Stifter, Matthews, Mangan, Fung, Drew, Tate, DeWeerd, Hertzog) Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, VIC 3168, Australia (Stifter, Matthews, Mangan, Fung, Drew, Tate, DeWeerd, Hertzog) Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, VIC 3168, Australia (Soares Da Costa) Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086, Australia (Hampsey, Mayall, Hansbro) Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia (Minambres, Eid, Mak) School of Medicine, Deakin University, Geelong, VIC 3220, Australia (Minambres, Eid, Mak) Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Geelong, VIC 3220, Australia (Mak) Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD 4222, Australia (Scoble, Lovrecz) CSIRO Manufacturing, Parkville, VIC 3052, Australia (Stifter) Mycobacterial Laboratory, Centenary Institute, Camperdown, NSW 2050, Australia (Fung) Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australiaen
dc.description.addressP.J. Hertzog, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, VIC 3168, Australia. E-mail: paul.hertzog@hudson.org.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailHertzog P.J.; paul.hertzog@hudson.org.auen
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Articles
Show simple item record

Page view(s)

22
checked on Feb 11, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.